Title : A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.

Pub. Date : 2016 Feb 24

PMID : 26912134






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Selumetinib (AZD6244, ARRY-142886) potently and selectively inhibits MEK1/2, an intracellular kinase and has shown activity in ABC. AZD 6244 mitogen-activated protein kinase kinase 1 Homo sapiens
2 Selumetinib (AZD6244, ARRY-142886) potently and selectively inhibits MEK1/2, an intracellular kinase and has shown activity in ABC. AZD 6244 mitogen-activated protein kinase kinase 1 Homo sapiens